V116517 50-mg tablets
DrugTaken orally twice daily
NCT Number: NCT01688947
The primary objective of this study is to evaluate the analgesic efficacy of 2 dose levels of V116517 versus placebo.
Looking for future studies?
Notify Me21 year–90 year
All sexes
Interventional
Phase 2
Investigational Site, Tucson, Arizona, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Key Inclusion Criteria:
Key Exclusion Criteria:
Other protocol specific inclusion/exclusion criteria may apply.
Taken orally twice daily
Taken orally twice daily
1-2 capsules taken orally twice daily
Tablets to match V116517 taken orally twice daily and/or placebo capsules to match pregabalin, 1-2 capsules taken orally twice daily
Time frame: Week 4
Time frame: Week 4
Time frame: Week 4
Time frame: Week 4
Time frame: Over 4 weeks
Purdue Pharma LP
Industry
A Phase 2, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Study Evaluating the Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00885586
DNA Virus Infections, Herpes Zoster
Munich, Bavaria, Germany
View Trial DetailsNCT01124617
Chronic Pain, Diabetes Complications
Chigasaki, Japan
View Trial DetailsNCT01228838
DNA Virus Infections, Herpes Zoster
Huntsville, Alabama, United States
View Trial DetailsNCT00478179
DNA Virus Infections, Herpes Zoster
La Jolla, California, United States
View Trial Details